Biotech expert Brad Loncar explains why COVID-19 should be taken seriously and goes in-depth on the companies rapidly developing treatments and vaccines. ETF.com’s Drew Voros highlights ETF flows and discusses the Fed’s decision to purchase investment grade corporate bond ETFs.
No transcript available.
POWERED BY BLUBRRY
